about
Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptidesCancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heartEffects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes.Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.The aortic ring model of angiogenesis: a quarter century of search and discovery.Therapeutic potential of neuropeptide Y (NPY) receptor ligands.NPY and stress 30 years later: the peripheral view.Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development.Central functions of neuropeptide Y in mood and anxiety disorders.The role of neuropeptides in adverse myocardial remodeling and heart failure.Current views on neuropeptide Y and diabetes-related atherosclerosis.Metoprolol, but not atenolol, reduces stress induced neuropeptide Y release in pigs.Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.Role of sympathetic cotransmitter galanin on autonomic balance in heart failure: an active player or a bystander?Targeted Orexin and Hypothalamic Neuropeptides for Migraine.The Role of Neuropeptide Y in Cardiovascular Health and Disease
P2860
Q27026280-761DC66B-7AF6-4A03-A8DB-1DB4ADA5C1ECQ30475241-8784A45B-1867-4B1B-8BF8-DE756B7CC0EBQ35101262-4BACC97B-1E66-4C25-80D9-A2DC2688A0F9Q35542861-6CC33C47-0D1D-4DF9-872C-22FCB7231557Q35660142-73608016-3EFF-44A1-86CB-E730B0607B51Q35832019-9106EE91-CA9C-422B-90C9-123E17ADDF94Q36088880-853E4573-51DF-4083-9497-0842A7AF6973Q36382828-A11EAB6A-0E42-4E91-B009-A802E31B42A9Q37158344-0D6D062D-EE28-4193-951C-67649870ECB7Q37847125-5808106D-A130-406F-9B98-5277F3147360Q37945311-234A19CE-14CE-4D06-A89D-F32EBD4682B7Q39093111-5F17A3DF-C55D-4D12-8BEB-60D6309BBA38Q39250869-6366FC62-944A-4BAA-9336-C77FEC12721FQ42809857-2D42590D-C319-458F-8AB4-ED4AE5A35D38Q43134806-9E29C49D-CCEE-4906-8CB4-DD590F37DFABQ47134261-02D09264-0FB5-484E-A8A0-71DC354DC8FAQ50016389-E33FD06D-DF53-4428-B8B1-988005736551Q57073005-602FD3F4-51C3-4EED-A469-1DF610A47166
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NPY and cardiac diseases.
@en
type
label
NPY and cardiac diseases.
@en
prefLabel
NPY and cardiac diseases.
@en
P1476
NPY and cardiac diseases.
@en
P2093
P304
P356
10.2174/156802607782340939
P577
2007-01-01T00:00:00Z